Bi-weekly docetaxel and 5-fluorouracil: an effective and feasible treatment for advanced gastric cancer with poor performance status

Background: The survival benefits from cytotoxic chemotherapy have been demonstrated in advanced gastric cancer (AGC). A large proportion of AGC patients initially present poor performance status (PS); however, most of the clinical evidence comes from trials on patients with good PS. A better-design...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Yuting, Li, Wenyun, Chen, Yonghe, Deng, Yanhong, Xiao, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219146/
https://www.ncbi.nlm.nih.gov/pubmed/25149319
http://dx.doi.org/10.1093/gastro/gou051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219146/
https://www.ncbi.nlm.nih.gov/pubmed/25149319
http://dx.doi.org/10.1093/gastro/gou051

Ejemplares similares